Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

Investor Relations

Change
Volume
52 Week High
52 Week Low

Copyright West LLC. Minimum 15 minutes delayed.

Events
News Releases
November 26, 2019
electroCore to Present at the Two December Investor Conferences
BASKING RIDGE, N.J. , Nov. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger , Chief Executive Officer, will present  a corporate overview and host investor meetings at the Evercore ISI HealthCONx 
November 13, 2019
electroCore Announces Third Quarter 2019 Financial Results
Continued growth in prescribing physicians, paid months of therapy and dispensed prescriptions Company to host conference call and webcast today, November 13 , at 4:30pm ET BASKING RIDGE, N.J. , Nov. 13, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic

Investor Contact

Investor Relations

Hans Vitzthum, LifeSci Advisors
investors@electrocore.com